Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

The latest news from Arcinova

July 9, 2019

Panel Discussion on Flow Chemistry

June 10, 2019

Arcinova continues rapid expansion with 30% increase in headcount

May 29, 2019

British contract research firms fight to find science talent

May 22, 2019

Mayor Jamie Driscoll Visits Our Alnwick Site

Our CEO and Chairman, Ian Shott a
May 9, 2019

Contract Pharma: ‘A Modern CDMO’ article

Our Head of Drug Substance, Paul Quigley, recently shared his thoughts on the
May 6, 2019

Dr Stephen Byard receives Award for Service

Morpeth’s Dr Stephen Byard has received The Royal Society of Chemistry Aw
April 26, 2019

Accelerating the path to first-in-human clinical trials

Our Head of Drug Substance, Paul Quigley, was recently interviewed by Outsourcing Pharma to coincide with his presentation at CPhI North America 2019. He explained the importance of ensuring rapid
April 17, 2019

Article: Chemistry 4.0 in pharmaceutical development

"The pharmaceutical industry is being revolutionised by the utilisation of digital technologies. Chemistry 4.0 describes this digital transformation and how its delivery is paving the way for the
April 16, 2019

Crédit d'impôt recherche Grants Arcinova with R&D Status

Arcinova has been recognised and approved by the Crédit d'impôt recherche (CIR) as an organisation undertaking R&D activities.  This will bestow significant benefits upon any French cus




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH